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Background and purpose   Dysplasia of the hip increases the 
risk of secondary degenerative change and subsequent total hip 
replacement. Here we report on age at diagnosis of dysplasia, pre-
vious treatment, and quality of life for patients born after 1967 
and registered with a total hip replacement due to dysplasia in 
the Norwegian Arthroplasty Register. We also used the medical 
records to validate the diagnosis reported by the orthopedic sur-
geon to the register. 
Methods   Subjects born after January 1, 1967 and regis-
tered with a primary total hip replacement in the Norwegian 
Arthroplasty Register during the period 1987–2007 (n = 713) 
were included in the study. Data on hip symptoms and quality of 
life (EQ-5D) were collected through questionnaires. Elaborating 
information was retrieved from the medical records. 
Results   540 of 713 patients (76%) (corresponding to 634 hips) 
returned the questionnaires and consented for additional infor-
mation to be retrieved from their medical records. Hip dysplasia 
accounted for 163 of 634 hip replacements (26%), 134 of which 
were in females (82%). Median age at time of diagnosis was 7.8 
(0–39) years: 4.4 years for females and 22 years for males. After 
reviewing accessible medical records, the diagnosis of hip dyspla-
sia was confirmed in 132 of 150 hips (88%). 
Interpretation   One quarter of hip replacements performed in 
patients aged 40 or younger were due to an underlying hip dys-
plasia, which, in most cases, was diagnosed during late childhood. 
The dysplasia diagnosis reported to the register was correct for 
88% of the hips.
 
Hip disorders in children, such as developmental dysplasia of 
the hip (DDH), Perthes’ disease, and slipped capital femoral 
epiphysis (SCFE) may lead to degenerative changes warrant-
ing a total hip replacement (THR) in young adults (Jacobsen et 
al. 2005). Dysplasia is the more common of these (Thillemann 
et al. 2008), with a reported prevalence of 0.5–4% according to 
time and type of ascertainment and the diagnostic criteria used 
(Rosendahl et al. 1996, Holen et al. 1999, Reikeras et al. 1999, 
Lehmann et al. 2000). Most patients with dysplasia are diag-
nosed during the newborn period by clinical screening tests 
and/or an additional ultrasound examination. However, despite 
early abduction treatment for those testing positive, the number 
of children in need of surgical intervention for DDH remains 
relatively stable, with a reported incidence of around 1 per 
1,000 (Godward and Dezateux 1998). As such, the different 
neonatal screening programs for DDH appear to have failed. 
Another issue is whether early abduction treatment may 
prevent later development of osteoarthritis (OA). OA due to 
hip dysplasia is reported in up to 8% of adults with a total 
hip replacement (Furnes et al. 2001, Lohmander et al. 2006, 
Engesaeter et al. 2008b). Females appear to be at a higher risk 
of developing OA than males (Furnes et al. 2001, Lohman-
der et al. 2006). In a previous registry-based study, dysplasia 
was reported to be the underlying cause in almost one third 
of all total hip replacements in patients under the age of 60 
(Furnes et al. 2001). Studies on quality of life in patients with 
OA secondary to hip dysplasia (Garbuz et al. 2008, Tellini et 
al. 2008) have shown that a hip replacement in most cases has 
a positive effect. 
We determined the frequency of DDH as the underlying 
cause of total hip replacement as reported to the Norwegian 
Arthroplasty Register for patients aged 40 or younger. Next, 
we examined the age at DDH diagnosis and the various hip-
preserving treatments received before the THR; thirdly, we 
examined the quality of life for patients with a THR; and 
finally, we validated the agreement between the dysplasia 
diagnosis reported by the orthopedic surgeon to the register 
and the diagnosis stated in the medical records.150  Acta Orthopaedica 2011; 82 (2): 149–154
Patients and methods
All patients born after January 1, 1967—which was when the 
Medical Birth Registry of Norway was established—and reg-
istered as having a primary total hip replacement in the Nor-
wegian Arthroplasty Register (NAR) during the period 1987 
through 2007, were included in the study. From 2005 to 2007, 
these individuals were approached by regular mail and invited 
to participate in a follow-up, including 2 questionnaires: one 
on the actual hip disease leading to THR and the other on their 
current general health situation.
The questionnaires
Data on hip symptoms and clinical history were obtained by 
self reporting, using both a custom-made questionnaire and 
a standardized, validated international questionnaire: EQ-5D. 
The custom-made questionnaire included, among others, a 
question on whether or not the patient agreed with the diagno-
sis that was registered in the Norwegian Arthroplasty Register. 
The EQ-5D is a descriptive tool assessing 5 dimensions: the 
level of mobility, self-care, usual activity, pain/discomfort, and 
anxiety/depression. Each question has 3 levels: no problems, 
some problems, and severe problems. A single, weighted util-
ity score—the EQ-5Dindex—is calculated from the 5 dimen-
sions (Dolan 1997). The “best imaginable health state” rep-
resents individuals who report that they are experiencing the 
highest level of function for the 5 conditions. The EQ-5Dindex 
score for these patients is 100. Death scores zero, but condi-
tions worse than death (< 0) are possible. The results from 
our study were compared with data from age-matched cohorts 
(18–39 years) from Sweden (46% women) and the UK (56% 
women) (Szende and Williams 2004). 
Analysis of questionnaire and collection of data from 
the medical notes
All patients were asked to confirm the nature of the underly-
ing hip disorder as registered in the NAR. If there was agree-
ment, and in cases with an evident underlying diagnosis such 
as a femoral neck fracture, rheumatoid arthritis, or ankylos-
ing spondylitis (Mb. Bechterew), collection of additional data 
from the medical records was judged unnecessary to ensure 
the quality of the data (n = 155). For the reminder (n = 479), 
having a diagnosis such as idiopathic osteoarthritis, sequelae 
of dysplasia with or without dislocation, sequelae of Perthes’/
SCFE or “others”, we retrieved additional information from 
the medical notes in 48 different hospitals throughout the 
country. Hospitals in which more than 5 patients were oper-
ated (n = 14) were visited by one of the authors (IØE, TL). 
The remaining hospitals (n = 34) were contacted by mail and 
asked to submit a copy of the medical records. 23 hospitals 
responded, providing data on 70 of the relevant 91 hips.
The medical records were reviewed by the same 2 authors 
(IØE, TL). From these records, we retrieved the primary hip 
diagnosis and classified the diagnosis as either “true”, “false”, 
or “equivocal”. Diagnoses found in the clinical record, sup-
ported by information on clinical findings, symptoms and 
radiological reports, were accepted as true. In most patients, 
we were unable to find radiographs taken at the time of diagno-
sis. This is due to national regulations where radiographs not 
used in the ensuing 10 years are normally destroyed. Unfortu-
nately, this made it impossible to validate the diagnosis on the 
basis of the primary radiographs. For patients diagnosed with 
DDH, Perthes’ disease, or SCFE, we also recorded date and 
symptoms at the time of diagnosis of the hip disease and treat-
ment given for the hip disorder until they underwent THR. 
Diagnoses reported to the Norwegian Arthroplasty 
Register
Since September 1987, total hip replacement procedures have 
been reported to the Norwegian Arthroplasty Register (NAR) 
(Havelin et al. 2000). A standard form including the patient’s 
unique 11-digit identity number, date of surgery, and indica-
tion for and type of THR is filled in by the surgeon and sub-
mitted to the registry. Both primary operations and reopera-
tions are recorded. Reporting to the NAR is not mandatory, but 
estimates suggest that there is a reporting frequency of at least 
97% of joint replacements performed in Norway (Espehaug et 
al. 2006). The diagnosis of hip dysplasia is split into 2 catego-
ries in the register: dysplasia and dysplasia with dislocation at 
the time of THR. In our analysis we merged the 2 alternatives, 
resulting in one output called “DDH”.
Statistics
Data were summarized using median and range or mean and 
standard deviation (SD) as appropriate. Comparison of mean 
values was done using t-tests, where a p-value of < 0.05 indi-
cated a statistically significant difference. The analyses were 
performed in the statistical program SPSS for Windows ver-
sion 17.0.
Ethics
In order to validate data in the Norwegian Arthroplasty Reg-
ister, the procedures were approved by the Regional Ethical 
Committee for Medical and Health Research. In addition, all 
patients returned a written informed consent form where they 
gave their permission to obtain further information from the 
medical records of the hospitals. Patients who did not give this 
consent were excluded from the study (n = 32).
Results
732 patients born after January 1, 1967 were registered in 
the Norwegian Arthroplasty Register as having undergone a 
primary THR. 540 patients (76%) were included in the study 
(corresponding to 634 hip replacements) (Figure 1). Mean 
age was 33 (SD 5.3) years and 300 of these patients were 
females. Acta Orthopaedica 2011; 82 (2): 149–154  151
According to the Arthroplasty Register, hip dysplasia 
accounted for 163 (26%) of the 634 hip replacements (Table 
1). We were unable to retrieve extended medical information 
for 13 hips, leaving us with 150 hips for validation. Of the 
150 THRs, the dysplasia diagnosis was confirmed by medical 
notes in 88% (132 hips, 114 patients). 18 hips (12%) were 
classified as having incorrect reporting. Of the incorrectly 
reported hips, reassessment revealed the following diagnoses: 
Perthes’ disease (n = 5), SCFE (n = 1), epiphyseal dysplasia (n 
= 5), sequelae following previous traumatic dislocation (n = 
2), previous avascular necrosis secondary to steroid therapy 
(n = 3), tuberculous coxitis (n = 1), and myelomeningocele 
with spasms (n = 1). In addition to those 132 already correctly 
reported hips, 10 hips were reclassified as hip dysplasia but 
these were not included in the analyses. 
The accuracy of the other diagnoses registered in the regis-
try varied from 93% to 100% (Table 1), with the exception of 
the group “idiopathic osteoarthritis” where only 61% of the 
diagnoses were validated as correct. All the diagnoses in the 
remaining 39% (12 hips) were judged as error reports. 4 of 
the incorrectly reported “idiopathic osteoarthritis” hips were 
validated as sequelae of dysplasia and 8 hips were classified 
as “other diagnosis”. 
Median age at the time of diagnosis of DDH was 7.8 (0–39) 
years: 4.4 years for females and 22 for males (Figure 2), with 
the more common symptoms/findings at presentation being 
limp (25%), hip pain (20%), and reduced hip abduction (18%).
Data on previous hip-preserving treatment (both surgery 
and nonoperative treatment) were retrieved for 88 of the 132 
confirmed dysplastic hips (67%) (Table 2). Previous surgery 
was reported for 81 of the 88 hips, femur osteotomy being 
the most common and seen in 63 (36%) of 176 surgical pro-
cedures. (More than 1 procedure during each operation was 
possible). Rotation and varisation were the two most common 
subtypes of the femur osteotomies. Different acetabular oste-
otomies were seen in 24% (43/176 procedures) of which Salter 
innominate osteotomy dominated (23/176 procedures). 14 
hips (19/176 procedures, 11%) had undergone open reduction.   
In 10 hips (9 patients, 12% of the total) early abduction treat-
ment with a Frejka pillow was given, but all of them were in 
need of hip preserving surgery later, i.e. none of those reported 
with only Frejka pillow as treatment received a THR later. 
Median age at the time of THR was 32 (14–40) years; this 
was similar in both sexes (Figure 3). 18 patients had been 
operated with bilateral prosthesis. 
Regarding the EQ-5D questions, 66% of the patients (n = 
75) reported having some pain or severe pain. 67 (59%) had 
problems with mobility and 62 (54%) had difficulties with 
daily activities. The mean EQ-5Dindex for men (score = 74) 
was slightly better than for women (score = 67), but the dif-
ference was not statistically significant (p = 0.2). The self-
reported health situation for patients who were operated due to 
Figure 1 Flow of participants in the study. 
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Table 1. Diagnosis underlying a total hip replacement in 540 patients, as recorded in the Norwegian Arthroplasty 
Register (NAR), compared to the diagnoses recorded in the initial medical records. 6 hips were registered with 
multiple diagnoses
Diagnoses  Diagnosis as  Hips available  NAR diagnosis  Other diagnosis
  registered in NAR  for validation  confirmed  confirmed
  (n hips)    n (%)   n (%)
  
Idiopathic osteoarthritis  42  31    19 (61)  12 (39)
Rheumatoid arthritis  114  112  109 (97)    3 (3)
Sequelae fractura colli femoris  27  26    25 (96)    1 (4)
Sequelae of dysplasia/
  sequelae of dysplasia with dislocation  163  150  132 (88)  18 (12)
Sequelae of Perthes’/SCFE   101  94    89 (95)    5 (5)
Ankylosis spondylitis (Mb. Bechterew)  28  28    28 (100)    0 (0)
Acute fractura colli femoris  2  2      2 (100)    0 (0)
Others  160  145  134 (92)  11 (8)
Missing diagnosis  4  4      0 (0)    4 (100)152  Acta Orthopaedica 2011; 82 (2): 149–154
DDH (score = 68) was worse than that reported for the general 
population aged from 18 to 39 years in Sweden (score = 86, 
p < 0.001) and in the United Kingdom (score = 87, p < 0.001). 
Discussion
According to data in the Norwegian Arthroplasty Register 
(NAR), hip dysplasia is the underlying cause in 1 
out of every 4 total hip replacements performed in 
patients aged 40 or younger. The diagnosis regis-
tered in the NAR was confirmed in 88% of the cases 
after review of the medical records. This figure com-
pares favorably with that reported for the Danish Hip 
Arthroplasty Register, in which the diagnosis was 
confirmed in 94% of patients with congenital hip dys-
plasia and in 81% of those with acetabular dysplasia 
(Pedersen et al. 2004). 
The median age at diagnosis of DDH was 7.8 years, 
which is indeed noteworthy, and in agreement with 
a previous study using data from the Medical Birth 
Registry of Norway and the Norwegian Arthroplasty 
Register (Engesaeter et al. 2008a). That study, involv-
ing 442 patients, showed that 92% of all patients 
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Figure 2. A. Age at diagnosis for females (n = 95). Median age at diagnosis was 
4.4 (0–38) years. B. Age at diagnosis for males (n = 9). Median age at diagnosis 
was 22 (9.5–39) years. 
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Table 2. Treatment prior to THR for the 132 hips with a confirmed 
DDH in the Norwegian Arthroplasty Register
Hips      n (%)    n (% of 88)
 
Hip preserving treatment    88 (67)
  Frejka pillow    10 (11)
  Hip spica cast    51 (58)
  Traction    41 (47)
  Orthosis      4 (5)
  Hip-preserving surgery    81 (92)
No treatment prior to THR    34 (26)
No information on prior treatment    10 (8)
Total  132 (100)
Age at operation
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Figure 3. A. A age at THR for females (n=115). Median age of operation 14 (14–
40) years. B. Age at THR for males (n=17). Median age of operation 33 (20–39) 
years.
who underwent THR due to an underlying dysplasia had no 
reported hip instability in the newborn period, as assessed 
on clinical examination. This may be a result of the fact that 
the clinical screening tests for DDH, i.e. the Barlow/Orto-
lani maneuvers, have low sensitivity and specificity for DDH 
(Rosendahl et al. 1996), or it may reflect problems in report-
ing to or registration in the Medical Birth Registry itself, or a 
combination of the two. However, the possibility of a stable 
but dysplastic hip at birth deterioriating throughout childhood, 
with development of secondary degenerative changes, offers 
an alternative explanation. Due to missing radiographs in our 
study, we could not determine whether or not the hip was sub-
luxed or dislocated at the time of diagnosis, or confined to 
the acetabulum alone, which would obviously have 
helped in our understanding of the disease.
There are 2 principles of surgical treatment of hip 
dysplasia: hip preservation surgery and joint replace-
ment. Different techniques with femoral and/or ace-
tabular osteotomies are the most well-established 
preservation procedures and are optional in severe 
acetabular dysplasia (Weinstein et al. 2004, Clohisy 
et al. 2009). Our study revealed that 81 of 132 hips 
(61%) in young adults had undergone hip preserva-
tion surgery before THR was performed. In accor-
dance with the recommended techniques described in 
the literature, the most common surgical procedures 
were femoral (rotation and/or varisation) and acetab-
ular osteotomies. 
THR is common in patients with DDH, after non-
operative options and/or less invasive surgery have 
proven to be insufficient. In many respects, our patient group 
differs from the average patient who has had a THR. They are 
younger and therefore probably more physically active, and 
have high demands regarding hip function. This may influ-
ence the results of a general health assessment such as the 
EQ-5D, as our cohort reported relatively low scores for qual-
ity of life—of around 67–72 out of 100—as compared to those 
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(85–90). Two thirds reported some degree of pain, anxiety, 
or depression, while three fifths experienced problems with 
mobility and half had difficulties with daily activities. Such 
information is crucial for the young DDH patient when differ-
ent treatment options are being discussed.
The strengths of our study are the population-based design, 
the high response rate, and the standardized and thorough 
assessment of an underlying hip diagnosis. In an earlier study, 
we showed that nearly all total hip replacements are reported 
to the Norwegian Arthroplasty Register, allowing for gener-
alization of the results (Espehaug et al. 2006). The response 
rate was high, and there is no reason to believe that the non-
responders differed regarding the underlying diagnosis from 
those who responded. Moreover, the collection of data from 
previous medical notes as well as reassessment of diagnoses 
was performed by only 2 physicians/researchers, both with a 
special interest in DDH.
There were several limitations to our study. First, the dys-
plasia diagnosis was based on medical records rather than on 
primary radiographs. During data collection, however, we 
noticed that most patients with DDH had undergone treat-
ment with follow-up before the THR, which had been well 
documented in the clinical and radiological notes. We were 
therefore able to validate the diagnosis without the support 
of radiographs. Another limitation is that we did not identify 
whether or not the hip disorder was secondary to a neurologi-
cal condition, such as cerebral palsy or meningomyelocele. 
However, these are rare conditions as compared to DDH, with 
a prevalence of 1–4 per 1,000 term infants (Johnson 2002, 
Frey and Hauser 2003), and as such would not have influenced 
our results significantly. Thirdly, missing reports and data are 
always a concern in cross-sectional studies. We lacked the 
medical records for 21 hips (3%), 13 of which were regis-
tered as dysplastic. These cases were, however, excluded from 
the study and only patients for whom both questionnaires and 
medical records existed were included in the final analysis. 
In conclusion, we have shown that 1 out of every 4 hip 
replacements performed in patients aged 40 or younger have 
been due to an underlying hip dysplasia, and that most of these 
were diagnosed in late childhood. Three quarters of them had 
undergone different hip-preserving treatments before their 
prosthesis. The Arthroplasty Register-based diagnoses were 
correct in 88% of the cases. 
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